Tamoxifen Magnus Pharmaceuticals

Product Overview: Tamoxifen Magnus Pharmaceuticals

Tamoxifen is a non-steroidal selective estrogen receptor modulator (SERM) that functions as a competitive antagonist at estrogen receptors in breast tissue while demonstrating agonist activity in bone and endometrial tissues. As an FDA-approved pharmaceutical compound (marketed as Nolvadex), tamoxifen serves as a widely recognised reference standard in estrogen receptor research applications. Magnus Pharmaceuticals supplies this compound in pharmaceutical-grade tablet form, enabling precise dosing protocols in controlled laboratory studies. Researchers investigating estrogen receptor modulation pathways rely on tamoxifen’s well-characterised mechanism of action and extensive published literature spanning decades of clinical and preclinical research. The selective tissue activity profile makes it particularly valuable for studies examining estrogen receptor function across different organ systems and cell types.

Laboratory Applications

Research scientists employ tamoxifen in diverse experimental protocols investigating estrogen receptor biology and hormonal signalling pathways. Cell culture studies utilise tamoxifen to examine estrogen receptor-mediated gene expression, while tissue-specific research explores its differential activity profiles across various organ systems. The compound’s role in modulating hypothalamic-pituitary-gonadal axis function makes it valuable for endocrine research applications. Oncology research laboratories frequently incorporate tamoxifen as a reference compound in studies examining estrogen-dependent cellular processes and receptor binding kinetics. Additionally, researchers studying bone metabolism and cardiovascular biology investigate tamoxifen’s tissue-selective agonist properties. The extensive pharmacological profile documented in peer-reviewed literature provides researchers with comprehensive baseline data for experimental design and result interpretation across multiple research domains.

Technical Specifications

Magnus Pharmaceuticals maintains strict quality control standards throughout the manufacturing process, ensuring consistent purity and potency for research applications. Each batch undergoes comprehensive analytical testing to verify identity, purity, and stability parameters. Researchers at Stroid UK Shop can access detailed certificates of analysis alongside comprehensive product documentation. The pharmaceutical tablet formulation provides enhanced stability and precise dosing capabilities compared to raw powder alternatives. Storage recommendations emphasise protection from light exposure to maintain compound integrity throughout extended research programmes. The established pharmaceutical manufacturing standards ensure reproducible results across multiple experimental protocols and research institutions.

Research Compliance

This tamoxifen product is supplied exclusively for in-vitro laboratory research and analytical purposes. Researchers should consult relevant institutional guidelines and regulatory frameworks before initiating experimental protocols. The compound requires appropriate laboratory safety protocols including proper ventilation, personal protective equipment, and secure storage facilities. Documentation requirements may include experimental protocols, safety assessments, and institutional approval for research applications. Scientists studying estrogen receptor mechanisms can access additional research compounds through our aromatase inhibitors collection, while complementary research tools are available in our SARMs category and peptides section. This product is not intended for human consumption, veterinary applications, or any non-research purposes, and must be handled by qualified laboratory personnel in appropriate research facilities only.

Related

• You can buy tamoxifen directly from the category listing.
• You can buy magnus pharmaceuticals from stock held in our own warehouses.
• More options are listed under the entire selection.